Full-Time
Senior – Software Engineer
Radiotherapy Positioning & Monitoring
Brainlab
1,001-5,000 employees
Medical software and hardware for surgeries
No salary listed
Munich, Germany
In Person
 Software Engineering |
|---|
Get referred to Brainlab
Find people who can refer or advise you
- Degree in Computer Science, Software Engineering or an equivalent education / working experience
- 3+ years professional experience in object-oriented software development
- Good proficiency in C++
- Profound knowledge of object-oriented programming (OOP), software development principles and design patterns
- Experience as a full-stack developer
- Very good communication skills in English; German is a plus
- Design, develop, and maintain robust and scalable software solutions
- Apply object-oriented design principles and established design patterns
- Contribute to system architecture, improvement of our existing software design and technical decision-making
- Work across the full technology stack, with a primary focus on backend and application logic (C++-based)
- Review code, mentor team members, and promote software engineering best practices
- Collaborate within a highly skilled, international Scrum team of software and project engineers
- Work closely with the team and the Product Owner to develop optimal solutions that address customer needs
- Present prototypes to customers and clinical experts, gathering and incorporating feedback
- Participate in clinical case visits and perform system testing in real clinical environments
- Basic knowledge and experience with ReactJS, TypeScript, and CSS are a plus
- German language proficiency is a plus
Brainlab is a medical technology company that creates software and hardware to improve surgeries, radiosurgery treatments, and operating room efficiency. It serves hospitals and clinics by providing digital tools that enhance surgical precision and patient outcomes. The core products include image-guided navigation, planning software, and connected hardware that work together to guide procedures. Revenue comes from selling software licenses, hardware devices, and ongoing subscription services that include updates and support. The company differentiates itself by offering integrated digital medical technologies that combine software and hardware for a seamless clinical workflow, backed by service agreements. Its goal is to help healthcare providers perform safer, more accurate procedures and run operating rooms more efficiently through data-driven tools and ongoing support.
Company Size
1,001-5,000
Company Stage
Early VC
Total Funding
$7.3M
Headquarters
Munich, Germany
Founded
1989
Get referred to Brainlab
Find people who can refer or advise you
Simplify's Take
What believers are saying
- FDA-cleared Spine Mixed Reality Navigation expands Brainlab's U.S. spine workflow opportunity.
- Brainlab's software and hardware platform supports recurring licenses, subscriptions, and service revenue.
- Its 4,000-hospital footprint creates cross-sell opportunities across neurosurgery, spine, trauma, and radiation.
What critics are saying
- Stereotaxis and other robotic platforms can displace Brainlab in hospital surgical budgets.
- The canceled Frankfurt IPO signals financing constraints for commercialization and expansion.
- Large hospital losses can cascade through regional purchasing groups and renewals.
What makes Brainlab unique
- Founded in 1989, Brainlab pioneers software-driven surgical and radiation workflows.
- Brainlab combines hardware, software, and imaging to improve critical surgeries and radiosurgery.
- It operates globally from Munich, with offices across 25 locations worldwide.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
Conference Attendance Budget
Professional Development Budget
Wellness Program
Mental Health Support
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Phone/Internet Stipend
Home Office Stipend
Health Insurance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 2%Brainlab and Precision NeuroMed have formed a strategic partnership to develop an AI-enabled treatment planning platform for convection enhanced delivery (CED) to the brain. Brainlab has taken an equity stake in the clinical-stage biotechnology company as part of the collaboration. The partnership aims to create a cloud-based CED Treatment Planning System that combines Brainlab's medical imaging expertise with Precision NeuroMed's molecular flow simulation software. The platform will use advanced imaging and AI-driven optimisation to personalise drug distribution, overcoming blood-brain barrier limitations that restrict most systemically administered drugs. Initial development will focus on supporting Precision NeuroMed's lead drug, PNM-201, for recurrent glioblastoma. The companies plan to expand the platform to enable delivery of therapies for epilepsy, Parkinson's disease, Alzheimer's disease and ALS.
Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, has been awarded a Patient Monitoring and Capital Equipment contract with Brainlab, expanding access to advanced surgical technology across VA and DoD facilities. The partnership adds capital equipment and patient monitoring solutions to Lovell's federal portfolio, which previously focused on consumables. Brainlab, a digital medical technology company operating in 4,000 hospitals across 120 countries, first partnered with Lovell in 2024. The company develops integrated hardware and software for surgery and radiation therapy. The contract builds on Lovell's strong 2025 performance, which included over $100 million in sales, expanded Defence Logistics Agency Electronic Catalog access, and pharmaceutical distribution accreditation. Founded in 2013, Lovell has appeared four times on the Inc. 5000 list.
Brainlab has received FDA 510(k) clearance and launched its Spine Mixed Reality Navigation system in the United States.
Medtech firm Brainlab has decided to postpone its planned initial public offering (IPO) in Frankfurt, which was expected to raise $378 million.
Brainlab AG is launching an IPO on the Frankfurt Stock Exchange to raise up to €200 million, aiming to enhance its digital healthcare ecosystem. The company reported record revenues of €239 million and a 22.4% EBITDA margin in the first half of FY 2024/25. The IPO proceeds will support commercialization, expansion into new clinical applications, and balance sheet strengthening. Brainlab targets mid-term revenue growth of 10-13% and an EBITDA margin in the mid-20s, with a long-term goal of up to 30%.